Potential blood biomarkers in chronic spontaneous urticaria
120. | Kolkhir, P., André, F., Church, M. K., Maurer, M., and Metz, M.: Potential blood biomarkers in chronic spontaneous urticaria. Clin. Exp. Allergy 2017: 47; 19-36. IF: 5.16 |
r.120
Found 489 hits.
120. | Kolkhir, P., André, F., Church, M. K., Maurer, M., and Metz, M.: Potential blood biomarkers in chronic spontaneous urticaria. Clin. Exp. Allergy 2017: 47; 19-36. IF: 5.16 |
r.120
145 | Weller, K., Viehmann, K., BrĂ€utigam, M., Krause, K., Siebenhaar, F., Zuberbier, T., and Maurer, M.+: Management of chronic spontaneous urticaria in real life â in accordance with the guidelines? A cross-sectional physician-based survey study. J. Eur. Acad. Dermatol. Venereol. 2013: 27; 43-50. IF: 2.78 |
5. | Maurer, M., Theoharides, T., Granstein, R., Kovanen, P. T., Bischoff, S. C., Befus, D., Vliagoftis, H., Forsythe, P., Kambe, N., Miyachi, Y., Henz, B. M., Piliponsky, A. M., Levi-Schaffer, F., Kitamura, Y., Bienenstock, J., and Galli, S. J.: What is the physiological function of mast cells? Exp. Dermatol. 2003: 12; 886-910. IF: 2.04 |
156. | Hallgren, J., Hellman, L., Maurer, M., Nilsson, G. P., Wernersson, S., Abrink, M., and Pejler, G.+: Novel aspects of mast cell and basophil function: highlights from the 9th meeting of the European Mast Cell and Basophil Research Network (EMBRN) â a Marcus Wallenberg Symposium. Allergy 2020: 75; 707-709. IF: 13.15 |
r.156
259 | Hawro, T., Lehmann, S., Altrichter, S., Fluhr, J. W., Zuberbier, T., Church, M. K., Maurer, M.+ and Metz, M.: Skin provocation tests may help to diagnose atopic dermatitis. Allergy 2016: 71; 1745-1752. IF: 7.36 |
489. |
Kröger, M.+, Scheffel, J., Shirshin, E. A., Schleusener, J., Meinke, M. C., Lademann, J., Maurer, M., and Darvin, M. E.: Label-free imaging of M1 and M2 macrophage phenotypes in the human dermis in vivo using two-photon excited FLIM. ELIFE 2022: 11; e72819. IF: 7.70 |
o.489
176 | Weller, K., Koti, I., Makris, M., and Maurer, M.+: Anxiety and depression seem less common in patients with autoreactive chronic spontaneous urticaria. Clin. Exp. Dermatol. 2013: 38; 870-873. IF: 1.23 |
414. | Kolkhir, P., Altrichter, S., Asero, R., Daschner, A., Ferrer, M., Giménez-Arnau, A., Hawro, T., Jakob, T., Kinaciyan, T., Kromminga, A., Konstantinou, G. N. Makris, M., Metz, M., Stahl Skov, P., Staubach, P., Sussman, G., Zhang, K., and Maurer, M.+: Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 2021: 13; 545-559. IF: 5.10 |
o.414
110. | Giménez-Arnau, A. M., Toubi, E., Marsland, A. M., and Maurer, M.: Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2016: 30, Suppl. 5; 25-32. IF: 3.52 |
r.110
378 | Fricke, J.+, Ăvila, G., Keller, T., Weller, K., Lau, S., Maurer, M., Zuberbier, T., and Keil, T.: Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy 2020: 75; 423-432. IF: 13.15 |
o.378